Newron PharmaceuticalsAz. Aktie
29,50
EUR
+2,40
EUR
+8,86
%
27,10
CHF
+2,10
CHF
+8,40
%
Werbung
Newron PharmaceuticalsAz. Aktie Analyse
| 05.01.12 | Newron PharmaceuticalsAz. hold | Vontobel Research | |
| 28.10.11 | Newron PharmaceuticalsAz. hold | Vontobel Research | |
| 21.10.11 | Newron PharmaceuticalsAz. hold | Vontobel Research | |
| 27.09.11 | Newron PharmaceuticalsAz. hold | Vontobel Research |
Werbung
Werbung